UPS has announced the launch of UPS Temperature True Cryo, which further broadens the scope of UPS temperature-sensitive shipping offerings to include cryogenic solutions for UPS healthcare customers.
The service includes real-time tracking and intervention services, which, when combined with UPS’s proactive monitoring, risk mitigation solutions and global network of control towers, will provide complete visibility for cryogenic shipments at every stage of the supply chain journey.
The expansion is the latest addition to the UPS Temperature True suite of solutions. The solution uses Cryoport’s leading-edge cryogenic and related technologies, which allow UPS customers to use liquid nitrogen stored in dry vapor form to keep products frozen at -150 degrees C for 10 days while in transit or storage. It can also be paired with the industry first risk management, intervention and insurance solution, UPS Proactive Response Secure, to provide coverage for time- and temperature-sensitive shipments.
“There is a growing spectrum of demand across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health, and we are excited to add UPS Temperature True Cryo to meet our clients’ needs,” said John Menna, UPS’s vice president of global strategy for healthcare logistics. “The value and irreplaceable nature of products requiring cryopreservation highlight the need for a combination of cryogenic capability and financial risk mitigation – Temperature True Cryo and UPS Proactive Response Secure are a great pairing.”